UnitedHealth Group managed to secure a profit of $10 million in the fourth quarter, despite taking a significant hit of $1.6 billion due to a large restructuring charge. The healthcare giant, which is the parent company of UnitedHealthcare, has been focusing on a financial turnaround under the leadership of CEO Stephen Hemsley.
The company’s financial turnaround strategy includes re-focusing on key markets, products, and geographies, aligning pricing discipline to account for higher medical trends, and re-baselining operations at Optum. In the fourth quarter and full-year 2025 earnings report, UnitedHealth revealed that it had completed various actions resulting in a charge of $1.6 billion, affecting its net income.
UnitedHealth reported a fourth-quarter net income of $10 million, a significant drop from $5.5 billion in the previous year. The full-year net income for 2025 was $12 billion, compared to $14.4 billion in 2024. The restructuring impact on earnings before income taxes amounted to $2.8 billion, which included costs related to a cyberattack and other restructuring activities.
As part of its restructuring efforts, UnitedHealthcare has decided to exit certain markets, leading to a decline in Medicare Advantage enrollment by more than 1.1 million older adults. This decision, along with market contractions in commercial risk and Medicaid businesses, is expected to reduce total enrollment in all medical plans to 47 million this year.
Despite facing higher-than-expected costs, UnitedHealthcare’s businesses are experiencing growth. The company reported a 12% year-over-year increase in revenues to $447.6 billion for the full year 2025. Revenues for the fourth quarter also saw a rise to $113 billion compared to $100.8 billion in the same period last year.
UnitedHealthcare’s revenues for 2025 increased by 16% to $344.9 billion, with an additional 415,000 individuals enrolled in health insurance plans. Optum, on the other hand, witnessed an 8% increase in revenues for the fourth quarter and a 7% increase for the full year.
CEO Stephen Hemsley expressed optimism about the company’s future, stating, “We confronted challenges directly and finished 2025 as a much stronger company, giving us the momentum to better serve those who count on us and continue to improve our core performance.” The company’s resilience and strategic initiatives position it well for continued growth and success in the healthcare industry.
